Correlation Between Kymera Therapeutics and Nurix Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Nurix Therapeutics, you can compare the effects of market volatilities on Kymera Therapeutics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Nurix Therapeutics.

Diversification Opportunities for Kymera Therapeutics and Nurix Therapeutics

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kymera and Nurix is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Nurix Therapeutics

Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 0.76 times more return on investment than Nurix Therapeutics. However, Kymera Therapeutics is 1.32 times less risky than Nurix Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  4,908  in Kymera Therapeutics on August 29, 2024 and sell it today you would lose (310.00) from holding Kymera Therapeutics or give up 6.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kymera Therapeutics  vs.  Nurix Therapeutics

 Performance 
       Timeline  
Kymera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Kymera Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Nurix Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kymera Therapeutics and Nurix Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kymera Therapeutics and Nurix Therapeutics

The main advantage of trading using opposite Kymera Therapeutics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.
The idea behind Kymera Therapeutics and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years